SCHEMBL3756198

SCHEMBL3756198

Nc1ccc(-c2nnc(C(F)(F)F)o2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.64
RAB9A P51151 7/20 0.64
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
KDM4E B2RXH2 6/20 0.55
ALDH1A1 P00352 4/20 0.55
HSD17B10 Q99714 4/20 0.55
HPGD P15428 3/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
MAPT P10636 2/20 0.55
GLA P06280 1/20 0.55
ALOX15 P16050 1/20 0.55
HDAC6 Q9UBN7 5/20 0.50
TP53 P04637 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
POLB P06746 2/20 0.46
KIF11 P52732 1/20 0.44
NOTUM Q6P988 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22116712 0.83 NPC1 (0.57) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22116919 0.81 NPC1 (0.56) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22116888 0.81 NPC1 (0.59) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL3228041 0.81 DGAT1 (0.55) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL22116917 0.81 NPC1 (0.57) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL10226381 0.81 RAB9A (0.64) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL21095771 0.81 HDAC6 (0.51) NPC1RAB9AKDM4EHSD17B10HPGD
SCHEMBL18460477 0.81 HDAC6 (0.48) NPC1RAB9AKDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL18422979 0.80 HDAC6 (0.47) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL601473 0.80 NPC1 (1.00) NPC1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220144815-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2022-05-12 US claimed
EP-3897154-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS Bayer Aktiengesellschaft (DE) 2021-10-27 EP claimed
WO-2020127974-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2020-06-25 WO claimed
US-20220144815-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2022-05-12 US disclosed
EP-3897154-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS Bayer Aktiengesellschaft (DE) 2021-10-27 EP disclosed
EP-3762367-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI Industries Ltd. (IN) 2021-01-13 EP disclosed
US-20210002232-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2021-01-07 US disclosed
US-20210002232-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2021-01-07 US disclosed
WO-2020127974-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2020-06-25 WO disclosed
WO-2019171234-A9 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2020-01-09 WO disclosed
WO-2019171234-A9 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2020-01-09 WO disclosed
WO-2019171234-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2019-09-12 WO disclosed
WO-2019171234-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES PI INDUSTRIES LTD. (IN) 2019-09-12 WO disclosed
US-20150232429-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE 2015-08-20 US disclosed
US-9018205-B2 Substituted pyrimidinyl-amines as protein kinase inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2015-04-28 US disclosed
EP-2200436-B1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS SCRIPPS RESEARCH INST (US) 2015-01-21 EP disclosed
US-8530480-B2 Substituted pyrimidinyl-amines as protein kinase inhibitors THE SCRIPPS RESEARCH INSTITUTE (US) 2013-09-10 US disclosed
US-20130231336-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2013-09-05 US disclosed
US-20100298312-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS THE SCRIPPS RESEARCH INSTITUTE (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002232-A1 HETEROCYCLIC COMPOUNDS AS FUNGICIDES CYP1A2, CYP1B1, CYP1A1 NPC1 2957/4885RAB9A 1332/4885MEN1 271/4885
US-20130231336-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS MAP3K20, MAP3K5, MAP3K7 NPC1 2489/4885RAB9A 2773/4885MEN1 4118/4885
US-20100298312-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS MAP3K20, MAP3K5, MAP3K7 NPC1 2489/4885RAB9A 2773/4885MEN1 4118/4885
US-20220144815-A1 1,3,4-OXADIAZOLES AND THEIR DERIVATIVES AS NEW ANTIFUNGAL AGENTS CYP51A1, ERG28, DPM1 NPC1 1800/4885RAB9A 4072/4885MEN1 2148/4885
US-20150232429-A1 SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS MAP3K20, MAP3K5, MAP3K7 NPC1 2489/4885RAB9A 2773/4885MEN1 4118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.